Core Viewpoint - The management team of Shuoshi Biotechnology has voluntarily agreed to salary reductions to support the company's operational optimization and enhance management efficiency amid ongoing financial struggles [2][3]. Salary Reduction Details - Eight senior executives, including Honorary Chairman Fang Yongsheng and Chairman & General Manager Wang Guoqiang, will see salary cuts ranging from 5% to 50%, effective from August 15, 2025 [3][4]. - The most significant reduction is a 50% cut for both Fang Yongsheng and Wang Guoqiang, while other executives will experience reductions of 40% and 10% [4]. Financial Performance - Shuoshi Biotechnology has faced consecutive years of losses, with a reported net loss of 374 million yuan in 2023, a decline of 120.45% year-on-year [7]. - For the first half of 2025, the company reported a revenue of 176 million yuan, a decrease of 1.05% compared to the previous year, and a net profit of 3.99 million yuan, down 86.35% year-on-year [7][8]. Executive Compensation - Despite the financial difficulties, seven executives had annual salaries exceeding one million yuan in 2024, with Fang Yongsheng earning 2.0643 million yuan and Wang Guoqiang earning 2.4399 million yuan [5][6]. - The company emphasizes that the salary adjustments reflect the management's commitment to the company's long-term development and recognition of its intrinsic value [4][5]. Market Position - As of August 28, the stock price of Shuoshi Biotechnology was 63.08 yuan per share, with a total market capitalization of 5.3 billion yuan [9].

北京商报讯(记者丁宁)8月27日晚间，硕世生物(688399)发布公告称，公司近日收到部分董事、监事及全 体高级管理人员主动出具的《关于自愿降薪的函》。当前，全球经济形势及行业环境面临诸多挑战，为 进一步支持公司优化运营成本、提升管理效率、增强持续竞争力，实现稳健发展战略目标，上述人员基 于对公司未来发展的坚定信心及共同担当，自愿提出调整薪酬。 具体来看，名誉董事长房永生，董事长、总经理王国强年薪下调50%；董事、副总经理刘中华，董事、 副总经理、董事会秘书胡园园，副总经理周国辉年薪下调40%；财务总监孟元元，职工监事贾兆强年薪 下调10%；职工监事顾丽娜年薪下调5%。 此外，硕世生物称，除进行薪酬调整外，公司还将持续推进降本增效举措、加大市场拓展力度，从多维 度提升公司的运营效率和市场竞争力。 硕世生物表示，本次降薪系公司董事、监事及高级管理人员在充分理解行业周期与市场环境的基础上， 主动与公司共度时艰、共谋长远发展的重要体现，充分展现了管理层对公司内在价值的高度认同及对未 来成长前景的强烈信心。公司对此表示高度赞赏和衷心感谢，并将持续优化经营，积极应对市场变化， 不断提升价值创造能力，切实维护全体股东利益 ...

Meeting Overview - The shareholder meeting of Jiangsu Shuoshi Biotechnology Co., Ltd. was held on August 27, 2025, at the company's conference room in Taizhou, Jiangsu [1] - A total of 111 ordinary shareholders attended the meeting, representing 37,537,572 voting rights, which accounts for 44.7559% of the company's total voting rights [1] Voting Results - All non-cumulative voting proposals were approved with a high level of agreement, including 99.9804% of votes in favor for one proposal and 99.8292% for another [1] - The voting results for the cash dividend proposal showed that the majority of shareholders supported the proposal, with detailed breakdowns provided for different shareholder categories [2] Legal Compliance - The lawyers present confirmed that the meeting's convening and voting procedures complied with relevant laws and the company's articles of association, ensuring the legality and validity of the meeting and its outcomes [3]

江苏硕世生物科技股份有限公司 除进行薪酬调整外，公司还将持续推进降本增效举措、加大市场拓展力度， 从多维度提升公司的运营效率和市场竞争力。公司董事会、监事会及管理层将坚 守初心，始终如一地恪尽职守、勤勉尽责，为公司及全体股东的长远利益不懈努 力。 关于公司部分董事、监事及全体高级管理人员自愿降 薪的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 江苏硕世生物科技股份有限公司（以下简称"公司"）近日收到部分董事、 监事及全体高级管理人员主动出具的《关于自愿降薪的函》。当前，全球经济形 势及行业环境面临诸多挑战，为进一步支持公司优化运营成本、提升管理效率、 增强持续竞争力，实现稳健发展战略目标，上述人员基于对公司未来发展的坚定 信心及共同担当，自愿提出调整薪酬。现将本次降薪有关事项公告如下： | 降薪对象 | 降薪幅度 | | | | | | 降薪期限 | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 名誉董事长房永生先 | | | | | | | | ...

证券代码：688399 证券简称：硕世生物 公告编号：2025-030 江苏硕世生物科技股份有限公司 2025年第一次临时股东大会决议公告 本公司董事会及全体董事保证公告内容不存在任何虚假记载、误导性陈述或 者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 重要内容提示： 本次会议是否有被否决议案：无 3、 董事会秘书胡园园出席本次会议，公司高级管理人员列席本次会议，公司聘 请的见证律师列席本次会议。 一、 会议召开和出席情况 （一） 股东大会召开的时间：2025 年 08 月 27 日 （二） 股东大会召开的地点：江苏省泰州市药城大道 837 号公司会议室 （三） 出席会议的普通股股东、特别表决权股东、恢复表决权的优先股股东及 其持有表决权数量的情况： | 1、出席会议的股东和代理人人数 | 111 | | --- | --- | | 普通股股东人数 | 111 | | 2、出席会议的股东所持有的表决权数量 | 37,537,572 | | 普通股股东所持有表决权数量 | 37,537,572 | | 3、出席会议的股东所持有表决权数量占公司表决权数量的比 | 44.7559 | | 例（% ...

SHANGHAI 8 Yin Chena Road Middle anahai 200120 PR Chine 上海市通力律师事务所关于江苏硕世生物科技股份有限公司 2025 年第一次临时股东大会的法律意见书 致:江苏硕世生物科技股份有限公司 上海市通力律师事务所(以下简称"本所")接受江苏硕世生物科技股份有限公司 (以下简称"公司")的委托,指派本所夏青律师、茹秋乐律师(以下简称"本所律师") 根据《中华人民共和国公司法》《中华人民共和国证券法》等法律法规和规范性文件(以 下统称"法律法规"）及《江苏硕世生物科技股份有限公司章程》(以下简称"公司章 程")的规定就公司 2025年第一次临时股东大会(以下简称"本次股东大会")相关 事宜出具法律意见。 本所律师已经对公司提供的与本次股东大会有关的法律文件及其他文件、资料予以 了核查、验证。在进行核查验证过程中,公司已向本所保证,公司提供予本所之文件中 的所有签署、盖章及印章都是真实的,所有作为正本提交给本所的文件都是真实、准确、 完整和有效的,且文件材料为副本或复印件的,其与原件一致和相符。 在本法律意见书中,本所仅对本次股东大会召集和召开的程序、出席本次股东 ...

硕世生物(688399.SH)公告称，公司近日收到部分董事、监事及全体高级管理人员主动出具的《关于自 愿降薪的函》。名誉董事长房永生、董事长兼总经理王国强等8人年薪将下调，下调幅度在5%至50%不 等，自2025年8月15日起生效。 ...

Core Viewpoint - A significant increase in mid-term cash dividends has been observed among listed companies, with over 290 companies announcing plans to distribute more than 1640 billion yuan in total [2][5]. Group 1: Mid-term Dividend Announcements - Companies such as Juchip Technology, Zhonggang Tianyuan, and Taihe Co. have announced their first mid-term dividend plans, with cash dividends of approximately 17.42 million yuan, 45.23 million yuan, and 90 million yuan respectively [3][4]. - China CRRC plans to distribute a cash dividend of 3.157 billion yuan, with a cash dividend ratio of 43.57% [3][4]. - Changan Automobile and Hengli Petrochemical also announced their first mid-term dividends, with cash dividends of 496 million yuan and 563 million yuan respectively [4]. Group 2: Overall Dividend Statistics - As of August 24, 2024, 294 companies have disclosed mid-term dividend plans, with a total planned distribution of 1647.07 billion yuan [5][6]. - Three companies are set to distribute over 10 billion yuan, with China Mobile leading at over 54 billion yuan and a cash dividend ratio exceeding 64% [5][6]. - The average cash dividend ratio for disclosed mid-term dividends is approximately 80.87%, a significant increase from 36.14% in 2024 [6]. Group 3: High Dividend Ratios - Sixteen companies have reported cash dividend ratios exceeding 100%, while the average for the remaining companies is around 38% [6][7]. - Shuoshi Biotechnology has the highest cash dividend ratio, proposing a cash dividend of 285 million yuan, which is 71.42 times its net profit for the period [6]. - Other companies, such as Yisheng Shares, have also reported high dividend ratios, with Yisheng proposing a cash dividend of 163 million yuan against a profit of 615.51 million yuan [6]. Group 4: Companies with Losses Still Distributing Dividends - Some companies, including Delin Hai, Haoyun Technology, and Lanshield Optoelectronics, are planning to distribute mid-term dividends despite reporting net losses [8].

Core Insights - A total of 1526 A-share listed companies disclosed their 2025 semi-annual reports, with 921 companies achieving year-on-year net profit growth, representing approximately 60.35% [1] - The electronic, transportation, agriculture, automotive, machinery, non-ferrous metals, home appliances, and social services sectors showed strong performance [1] Group 1: Company Performance - Among the 1526 companies, 761 reported net profit growth exceeding 10%, 501 exceeded 30%, 359 exceeded 50%, 210 exceeded 100%, and 66 exceeded 300% [1] - Notable companies with significant net profit growth include Shumatech, XianDa Co., Zhimingda, Rongzhi Rixin, Shijia Photon, and Suotong Development [1] - 567 companies reported net profits over 100 million yuan, 180 over 500 million yuan, 88 over 1 billion yuan, 19 over 5 billion yuan, and 8 over 10 billion yuan [2] - China Mobile, Kweichow Moutai, CATL, China Telecom, Sinopec, Industrial Fulian, Muyuan Foods, Huaneng International, and Luoyang Molybdenum were among the top net profit earners [2] Group 2: Industry Performance - The electronic, transportation, agriculture, automotive, machinery, non-ferrous metals, home appliances, and social services sectors showed strong revenue performance [3] - In the electronic sector, companies in consumer electronics and semiconductors performed exceptionally well [3] - In agriculture, companies in breeding and animal health sectors showed significant performance improvements [3] - Muyuan Foods achieved revenue of 764.63 billion yuan, a year-on-year increase of 34.46%, and net profit of 107.9 billion yuan, a year-on-year increase of 952.92% [3] Group 3: Dividend Announcements - A total of 265 A-share listed companies announced their 2025 mid-term dividend plans [4] - 188 companies plan to distribute cash dividends exceeding 1 yuan per 10 shares, 77 companies exceeding 3 yuan, 38 companies exceeding 5 yuan, and 15 companies exceeding 10 yuan [4] - Notable companies with high cash dividends include JiBit, Ninebot, Shuoshi Bio, China Mobile, Dongpeng Beverage, Siwei Liekong, Dong'a Ejiao, and Aimeike [4] - Among the 265 companies, 111 plan to distribute over 100 million yuan, 77 over 200 million yuan, and 37 over 500 million yuan in dividends [4] Group 4: Specific Company Announcements - China CNR announced revenue of 1197.58 billion yuan, a year-on-year increase of 32.99%, and net profit of 72.46 billion yuan, a year-on-year increase of 72.48% [5] - The company plans to distribute cash dividends of 31.57 billion yuan [5]

Group 1 - The stock price of Shuoshi Biological as of August 22, 2025, closed at 63.56 yuan, down 1.00% from the previous trading day [1] - The company opened at 64.42 yuan, reached a high of 64.72 yuan, and a low of 63.52 yuan, with a trading volume of 1.11 billion yuan and a turnover rate of 2.07% [1] - Shuoshi Biological specializes in the research, production, and sales of in vitro diagnostic reagents, covering areas such as infectious diseases and tumor markers [1] Group 2 - The company has recently sparked market discussions due to its dividend plan, proposing a cash dividend of 34 yuan for every 10 shares, totaling 285 million yuan, with a dividend payout ratio of 7142.28% [1] - Notably, the company's net profit for the first half of the year was only 3.99 million yuan, indicating that the dividend amount significantly exceeds its current profit level [1] - On August 22, the net outflow of main funds for Shuoshi Biological was 13.31 million yuan, with a cumulative net outflow of 48.88 million yuan over the past five days [1]